Why Michele and Kent Stahl and their family made a $1,000,000 gift to CMT Research Foundation to develop treatments for CMT1A
Michele and Kent’s son, Austin, was diagnosed with CMT1A when he was 16 years old. Having difficulty with his balance and walking, it took years for him and his family to understand the cause. His mother Michele recounts, “we spent seven years searching for an answer....How the CMT Research Foundation Catalyzes Research into CMT
An Interview with RareCast’s Danny Levine Part of our mission at CMT Research Foundation is to raise awareness about the progress we are making in finding a cure for CMT in the medical, scientific, pharma and patient communities. So, I was pleased to be...
Be the Change We Wish to See: Join the Spring CMT Research Challenge
By: Chelsea Layton, living with CMT1A My name is Chelsea, and I have CMT1A. The disease is scattered throughout my dad’s side of the family. I’ve been recovering from my 10th foot surgery due to CMT for five months. My weeks consist of endless...
7 Ideas for Personal Fundraising Success
By: Chelsea Layton, living with CMT1A If you want to make a difference in Charcot-Marie-Tooth disease research but fundraising feels overwhelming to you, have no fear! Getting started in fundraising is easier than you think. Fundraising isn’t about holding elaborate...
Losing My Independence is Not Rare to Me
By: Monica Thomas, living with CMT2A When I was a kid and would watch movies in which wishes came true, excitement would build in my belly as I imagined my own wish being granted — what if I could rub a lamp and wish CMT away? Thoughts of life without CMT would race...
Important Research News Announcements
- A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice May 17, 2022
- Original Surgical Treatment and Long-term Follow-up for Chronic Inflammatory Demyelinating Polyradiculoneuropathy Causing A Compressive Cervical Myelopathy May 17, 2022
- Structural insights into Charcot-Marie-Tooth disease-linked mutations in human GDAP1 May 5, 2022
- Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice May 2, 2022
- Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A April 19, 2022
- Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene April 12, 2022
- Dosage effects of PMP22 on nonmyelinating Schwann cells in hereditary neuropathy with liability to pressure palsies April 9, 2022
- The Antiepileptic Valproic Acid Ameliorates Charcot-Marie-Tooth 2W (CMT2W) Disease-Associated HARS1 Mutation-Induced Inhibition of Neuronal Cell Morphological Differentiation Through c-Jun N-terminal Kinase April 5, 2022
- Therapeutic Potential of CKD-504, a Novel Selective Histone Deacetylase 6 Inhibitor March 30, 2022
- Curcumin and Ethanol Effects in Trembler-J Schwann Cell Culture March 29, 2022
